A multi-basin seasonal streamflow model for the Sierra Nevada

Linear regression models are constructed to predict seasonal runoff by fitting streamflow to temperature, precipitation, and snow water content across a range of elevations. The models are quite successful in capturing the differences in discharge between different elevation watersheds and their interannual variations. This exercise thus provides insight into seasonal changes in streamflow at different elevation watersheds that might occur under a changed climate

VLSI implementation of an energy-aware wake-up detector for an acoustic surveillance sensor network

We present a low-power VLSI wake-up detector for a sensor network that uses acoustic signals to localize ground-base vehicles. The detection criterion is the degree of low-frequency periodicity in the acoustic signal, and the periodicity is computed from the "bumpiness" of the autocorrelation of a one-bit version of the signal. We then describe a CMOS ASIC that implements the periodicity estimation algorithm. The ASIC is functional and its core consumes 835 nanowatts. It was integrated into an acoustic enclosure and deployed in field tests with synthesized sounds and ground-based vehicles.Fil: Goldberg, David H.. Johns Hopkins University; Estados UnidosFil: Andreou, Andreas. Johns Hopkins University; Estados UnidosFil: Julian, Pedro Marcelo. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad Nacional del Sur. Departamento de Ingeniería Eléctrica y de Computadoras; ArgentinaFil: Pouliquen, Philippe O.. Johns Hopkins University; Estados UnidosFil: Riddle, Laurence. Signal Systems Corporation; Estados UnidosFil: Rosasco, Rich. Signal Systems Corporation; Estados Unido

Winter climate variability and snowpack in the West

Snowpack is an important source of water supply in the western United States. This study examines the seasonal variability of an extensive history of snow observations over the western United States and Canada. It links variations in snowpack to variations in atmospheric circulation, surface temperature, and precipitation

A miniature, lowpower , intelligent sensor node for persistent acoustic surveillance

ABSTRACT The desire for persistent, long term surveillance and covertness places severe constraints on the power consumption of a sensor node. To achieve the desired endurance while minimizing the size of the node, it is imperative to use application-specific integrated circuits (ASICs) that deliver the required performance with maximal power efficiency while minimizing the amount of communication bandwidth needed. This paper reviews our ongoing effort to integrate several micropower devices for low-power wake-up detection, blind source separation and localization and pattern classification, and demonstrate the utility of the system in relevant surveillance applications. The capabilities of each module are presented in detail along with performance statistics measured during recent experiments

Progress with the Prime Focus Spectrograph for the Subaru Telescope: a massively multiplexed optical and near-infrared fiber spectrograph

The Prime Focus Spectrograph (PFS) is an optical/near-infrared multi-fiber spectrograph with 2394 science fibers, which are distributed in 1.3 degree diameter field of view at Subaru 8.2-meter telescope. The simultaneous wide wavelength coverage from 0.38 um to 1.26 um, with the resolving power of 3000, strengthens its ability to target three main survey programs: cosmology, Galactic archaeology, and galaxy/AGN evolution. A medium resolution mode with resolving power of 5000 for 0.71 um to 0.89 um also will be available by simply exchanging dispersers. PFS takes the role for the spectroscopic part of the Subaru Measurement of Images and Redshifts project, while Hyper Suprime-Cam works on the imaging part. To transform the telescope plus WFC focal ratio, a 3-mm thick broad-band coated glass-molded microlens is glued to each fiber tip. A higher transmission fiber is selected for the longest part of cable system, while one with a better FRD performance is selected for the fiber-positioner and fiber-slit components, given the more frequent fiber movements and tightly curved structure. Each Fiber positioner consists of two stages of piezo-electric rotary motors. Its engineering model has been produced and tested. Fiber positioning will be performed iteratively by taking an image of artificially back-illuminated fibers with the Metrology camera located in the Cassegrain container. The camera is carefully designed so that fiber position measurements are unaffected by small amounts of high special-frequency inaccuracies in WFC lens surface shapes. Target light carried through the fiber system reaches one of four identical fast-Schmidt spectrograph modules, each with three arms. Prototype VPH gratings have been optically tested. CCD production is complete, with standard fully-depleted CCDs for red arms and more-challenging thinner fully-depleted CCDs with blue-optimized coating for blue arms.Comment: 14 pages, 12 figures, submitted to "Ground-based and Airborne Instrumentation for Astronomy V, Suzanne K. Ramsay, Ian S. McLean, Hideki Takami, Editors, Proc. SPIE 9147 (2014)

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Background: Glucagon-like peptide 1 receptor agonists differ in chemical structure, duration of action, and in their effects on clinical outcomes. The cardiovascular effects of once-weekly albiglutide in type 2 diabetes are unknown. We aimed to determine the safety and efficacy of albiglutide in preventing cardiovascular death, myocardial infarction, or stroke. Methods: We did a double-blind, randomised, placebo-controlled trial in 610 sites across 28 countries. We randomly assigned patients aged 40 years and older with type 2 diabetes and cardiovascular disease (at a 1:1 ratio) to groups that either received a subcutaneous injection of albiglutide (30–50 mg, based on glycaemic response and tolerability) or of a matched volume of placebo once a week, in addition to their standard care. Investigators used an interactive voice or web response system to obtain treatment assignment, and patients and all study investigators were masked to their treatment allocation. We hypothesised that albiglutide would be non-inferior to placebo for the primary outcome of the first occurrence of cardiovascular death, myocardial infarction, or stroke, which was assessed in the intention-to-treat population. If non-inferiority was confirmed by an upper limit of the 95% CI for a hazard ratio of less than 1·30, closed testing for superiority was prespecified. This study is registered with ClinicalTrials.gov, number NCT02465515. Findings: Patients were screened between July 1, 2015, and Nov 24, 2016. 10 793 patients were screened and 9463 participants were enrolled and randomly assigned to groups: 4731 patients were assigned to receive albiglutide and 4732 patients to receive placebo. On Nov 8, 2017, it was determined that 611 primary endpoints and a median follow-up of at least 1·5 years had accrued, and participants returned for a final visit and discontinuation from study treatment; the last patient visit was on March 12, 2018. These 9463 patients, the intention-to-treat population, were evaluated for a median duration of 1·6 years and were assessed for the primary outcome. The primary composite outcome occurred in 338 (7%) of 4731 patients at an incidence rate of 4·6 events per 100 person-years in the albiglutide group and in 428 (9%) of 4732 patients at an incidence rate of 5·9 events per 100 person-years in the placebo group (hazard ratio 0·78, 95% CI 0·68–0·90), which indicated that albiglutide was superior to placebo (p<0·0001 for non-inferiority; p=0·0006 for superiority). The incidence of acute pancreatitis (ten patients in the albiglutide group and seven patients in the placebo group), pancreatic cancer (six patients in the albiglutide group and five patients in the placebo group), medullary thyroid carcinoma (zero patients in both groups), and other serious adverse events did not differ between the two groups. There were three (<1%) deaths in the placebo group that were assessed by investigators, who were masked to study drug assignment, to be treatment-related and two (<1%) deaths in the albiglutide group. Interpretation: In patients with type 2 diabetes and cardiovascular disease, albiglutide was superior to placebo with respect to major adverse cardiovascular events. Evidence-based glucagon-like peptide 1 receptor agonists should therefore be considered as part of a comprehensive strategy to reduce the risk of cardiovascular events in patients with type 2 diabetes. Funding: GlaxoSmithKline

Smart Structure Active Sonar Echo Cancellation Using Frequency Scheduled Control

Practical applications of smart structure technology to active acoustic noise control demand high performance at low cost. Typically, performance increases achieved by reducing control system latency are expensive. Furthermore, sonar echo cancellation is concerned with a wide frequency range for which linear time-invariant (LTI) controllers provide inadequate performance, and no direct error measurement is available to drive adaptive controllers. Real-time estimators of the cancellation error have been proposed to enable the use of adaptive controllers, however this significantly increases the system cost. In this paper, we introduce a frequency scheduled control architecture for echo cancellation which achieves adaptive control performance at LTI control prices, by exploiting the narrow instantaneous bandwidth commonly associated with individual sonar pings. Keywords: active noise control, noise cancellation, echo cancellation, frequency scheduled control 1. INTRODUCTION Over the p..